Philips shares are trading lower after the FDA said the company's data and analysis on recall devices were inadequate.
Portfolio Pulse from Benzinga Newsdesk
Philips shares are trading lower following the FDA's statement that the company's data and analysis on recall devices were inadequate.
October 06, 2023 | 10:10 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Philips' stock price is trading lower due to the FDA's criticism of the company's data and analysis on recall devices.
The FDA's criticism of Philips' data and analysis on recall devices is a negative development for the company. This could potentially lead to further regulatory scrutiny and impact the company's reputation, which is why the stock price is trading lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100